A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine TumorsNadine S. Jahchan, Julien Sage, Anne‐Flore Zmoos et al.|Cancer Discovery|2013Cited by 365
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylationGlenn S. Van Aller, Ryan G. Kruger, Nicolas Reynoird et al.|Epigenetics|2012Cited by 174
Abstract 4610: A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumorsNadine S. Jahchan, Julien Sage, Joel T. Dudley et al.|Cancer Research|2014Cited by 2